{"database": "openregs", "table": "documents", "rows": [["FDA-2020-D-1137-0086", "FDA", "FDA-2020-D-1137", "Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing - Guidance for Industry - June 2020", "Supporting & Related Material", "Background Material", "2021-02-22T05:00:00Z", 2021, 2, null, null, "2021-02-22T16:33:35Z", null, 0, 0, "0900006484a46b7c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2020-D-1137-0086"], "units": {}, "query_ms": 110.9200770733878, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}